Skip to main content

Table 3 Psychopharmacological medication

From: Sex difference in cerebrospinal fluid/blood albumin quotients in patients with schizophreniform and affective psychosis

 

All patients (N = 989)

Statistics

Females (N = 545; 55%)

Males (N = 444; 45%)

Overall psychopharmacological treatment

 Yes

498 (94%)

415 (95%)

Chi2 = 0.811 p = 0.368

 No

34 (6%)

22 (5%)

 Unknown

13 (1%)

7 (2%)

Antidepressants

 Overall

295 (59%)

221 (53%)

 

 Tricyclic

31 (11%)

28 (13%)

 SSRI, SNRI, NDRI, NARI

261 (88%)

188 (85%)

 MAO inhibitors

3 (1%)

5 (2%)

Antipsychotics

 Overall

384 (77%)

286 (69%)

 

 “Typical”

83 (17%)

59 (14%)

 Low-potency

61 (73%)

39 (66%)

 Medium-potency

0 (0%)

0 (0%)

 High-potency

22 (27%)

20 (34%)

 “Atypical”

356 (71%)

263 (63%)

Mood stabilizers

 Lithium

92 (18%)

57 (14%)

 

 Anticonvulsants

85 (17%)

58 (14%)

Benzodiazepines

87 (17%)

58 (14%)

Number of different medication classes per patient

 Same class/only one drug

174 (35%)

202 (49%)

 

 Two drugs

189 (38%)

135 (33%)

 Three drugs

97 (19%)

68 (16%)

 Four drugs

35 (7%)

10 (2%)

 Five drugs

3 (0.6%)

0 (0%)

  1. SSRI, selective-serotonin-reuptake-inhibitor; SNRI, serotonin-noradrenalin-reuptake-inhibitor; NDRI, norepinephrine-dopamine-reuptake-inhibitor; NARI, noradrenalin-reuptake-inhibitor; MAO, monoamine oxidase